National treatment guideline ENT—MOH 201534
|
National treatment guidelines for CAP—MOH 202035
|
National treatment guidelines for AECOPD treatment 201837
|
National treatment guidelines for implementing antimicrobial stewardship (AMS) in hospital—MOH 202036
|
International antibiotic prescribing guidelines |
IDSA 2007: Infectious Diseases Society of America. Guidelines on the management of CAP in adults38
|
BTS 2009: British Thoracic Society guidelines for the management of CAP in adults39
|
IDSA 2011 (endorsed by AAP): The management of CAP in infants and children older than 3 months of age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America40
|
BTS 2011: British Thoracic Society guidelines for the management of CAP in children: update 201141
|
IDSA 2012: IDSA Clinical Practice Guideline for ABRS in children and adults42
|
AAP 2013: American Academy of Pediatrics. The diagnosis and management of AOM43
|
NICE 2014: Diagnosis and management of community- and hospital-acquired pneumonia in adults44
|
INESSS 2016: Insitut national d’excellence en santé et en services sociaux. Acute rhinosinusitis in adults45
|
INESSS 2016: Insitut national d’excellence en santé et en services sociaux Acute rhinosinusitis in children46
|
INESSS 2016: Insitut national d’excellence en santé et en services sociaux AOM in children 3 months of age or older47
|
NICE 2017: Sinusitis (acute) antimicrobial prescribing48
|
INESSS 2017: Insitut national d’excellence en santé et en services sociaux CAP in adults49
|
IDSA 2019: Diagnosis and treatment of adults with CAP. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America50
|
NICE 2019: Pneumonia (community-acquired): antimicrobial prescribing51
|
WHO 2019: World Health Organization Model List of Essential Medicines52
|
EPOS 2020: EPOS 2020—European Position Paper on Rhinosinusitis and Nasal polyps53
|